June 24, 2024 02:15 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Shooting at a grocery store in USA leaves three people dead, 10 hurt | Sheikh Hasina, Narendra Modi engage in bilateral talks | As Chandrababu Naidu's new govt demolishes YSRCP office citing illegality, Jagan Reddy cries 'vendetta politics' | Centre notifies stringent anti-paper leak law amid exam mess, accused to face jail term, fine up to a crore | Maharashtra Congress chief Nana Patole alleges cracks on Atal Setu, BJP hits back

Torrent Pharmaceuticals Q4FY24 PAT grows 57% to Rs 449 cr

Mumbai: Torrent Pharmaceuticals Ltd reported a 57 percent increase in its consolidated net profit for the March quarter, reaching Rs 449 crore compared to Rs 287 crore in the same period last year, media reported.

Cipla promoters sell 2.53% stake in company for Rs 2,637 cr

Mumbai: The promoters of Cipla have sold a 2.53% stake in the company for 'creating liquidity' for specific needs including 'philanthropy', the Mumbai headquartered pharma major said on Wednesday.

Cipla Q4FY24: Net profit grows 79% YoY to Rs 939 cr

Mumbai: Pharma giant Cipla’s consolidated net profit grew 79% rising to Rs 939.04 crore in Q4 FY24 over Q4 FY23.

Sanofi collaborates with Dr. Reddy’s Labs to promote and distribute its vaccine brands in India

New Delhi: Hyderabad-based pharmaceutical major Dr. Reddy’s Laboratories Limited (DRL) on Wednesday announced an exclusive partnership with Sanofi Healthcare India Private Limited to promote and distribute Sanofi’s vaccine brands across the country.

Sanofi partners with Cipla to distribute and promote its Central Nervous System product range in India

Mumbai: Pharma companies Sanofi India and Cipla Limited on Tuesday announced an exclusive partnership for the distribution and promotion of Sanofi India’s Central Nervous System (CNS) product range in India.

Sun Pharma FY24 Sept qtr net profit grows 5% to Rs 2,376 cr

Mumbai: Leading pharma company Sun Pharmaceutical Industries Ltd Wednesday reported a 5% increase in its net profit for the July-September quarter, reaching Rs 2,375.5 crore compared to Rs 2,262.2 crore in the corresponding period last year.

India poised to become 'global hub for medicines': DCGI

New Delhi: There has been a fourfold increase in applications of the investigational new drugs in the country, according to Dr VG Somani, Drug Controller General of India (DCGI), media reports said.